ENDRA Life Sciences (NDRA) Receivables (2017 - 2018)
ENDRA Life Sciences (NDRA) reported Receivables of $12275.0 for Q3 2018, up 4.29% quarter-over-quarter from $11770.0 in Q2 2018.
ENDRA Life Sciences (NDRA) Receivables (2017 - 2018) Analysis & Trends
ENDRA Life Sciences (NDRA) has 2 years of Receivables data on file, last reported at $12275.0 in Q3 2018.
- Receivables for Q3 2018 came in at $12275.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2018 was $12275.0 (changed N/A YoY), and the FY2017 annual result was $6850.0, changed N/A from the prior year.
- Receivables advanced to $12275.0 in Q3 2018 per NDRA's latest filing, from $11770.0 in the prior quarter.
- Over five years, Receivables peaked at $12275.0 in Q3 2018 and troughed at $6850.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 1.75 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 10.89 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 3.82 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 922.24 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 1.82 Bn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 5.16 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 417.60 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 761.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 751.11 Mn |
| 10 | ENDRA Life Sciences | 5.25 Mn | 4.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 12,275.00 |
| Jun 30, 2018 | 11,770.00 |
| Mar 31, 2018 | 11,770.00 |
| Dec 31, 2017 | 6,850.00 |